General Information of the Compound
Compound ID
CP0515363
Compound Name
2-(1-propylazetidin-3-yl)-1H-1,3-benzodiazole-4-carboxamide
    Show/Hide
Structure
Formula
C14H18N4O
Molecular Weight
258.325
Canonical SMILES
CCCN1CC(C1)c1nc2cccc(C(N)=O)c2[nH]1
    Show/Hide
InChI
InChI=1S/C14H18N4O/c1-2-6-18-7-9(8-18)14-16-11-5-3-4-10(13(15)19)12(11)17-14/h3-5,9H,2,6-8H2,1H3,(H2,15,19)(H,16,17)
    Show/Hide
InChIKey
CCQGGHBBNRXBIY-UHFFFAOYSA-N
Physicochemical Property
logP
1.471
Rotatable Bonds
4
Heavy Atom Count
19
Polar Areas
75.01
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25190725
ChEMBL ID
CHEMBL452785
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00839, Poly [ADP-ribose] polymerase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000337 C-4-I Homo sapiens (Human)  1
1
EC50 = 16 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 17 nM